Identification and evaluation of the novel immunodominant antigen Rv2351c from Mycobacterium tuberculosis

Identification and evaluation of the novel immunodominant antigen Rv2351c from Mycobacterium tuberculosis

There is an urgent need for new immunodominant antigens to improve the diagnosis of tuberculosis (TB) and the efficacy of the TB vaccine to control the disease worldwide. In this study, we evaluated the diagnostic potential of a novel Mycobacterium tuberculosis (MTB)-specific antigen, Rv2351c, from...

Full description

Bibliographic Details
Main Authors: Xuezhi Wang, Shuangshuang Chen, Yongjuan Xu, Huajun Zheng, Tongyang Xiao, Yuqing Li, Xing Chen, Mingxiang Huang, Haifeng Zhang, Xijing Fang, Yi Jiang, Machao Li, Haican Liu, Kanglin Wan
Format: Article
Language:English
Published: Taylor & Francis Group 2017-01-01
Series:Emerging Microbes and Infections
Subjects:
cytokine
immunogenicity
Mycobacterium tuberculosis
Rv2351c
vaccine
Online Access:https://www.tandfonline.com/doi/10.1038/emi.2017.34

Internet

https://www.tandfonline.com/doi/10.1038/emi.2017.34

Similar Items